CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 35 filers reported holding CARDIOME PHARMA CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $62,000 | -3.1% | 13,800 | -35.5% | 0.00% | – |
| Q1 2017 | $64,000 | -62.6% | 21,379 | -65.6% | 0.00% | – |
| Q4 2016 | $171,000 | -20.5% | 62,067 | -9.5% | 0.00% | – |
| Q3 2016 | $215,000 | +83.8% | 68,581 | +199.5% | 0.00% | – |
| Q2 2016 | $117,000 | +25.8% | 22,900 | +99.1% | 0.00% | – |
| Q4 2015 | $93,000 | -94.8% | 11,500 | -94.5% | 0.00% | -100.0% |
| Q3 2015 | $1,778,000 | +11.3% | 210,620 | +24.1% | 0.00% | – |
| Q2 2015 | $1,597,000 | +71.9% | 169,752 | +69.2% | 0.00% | – |
| Q1 2015 | $929,000 | +29.4% | 100,334 | +29.2% | 0.00% | – |
| Q4 2014 | $718,000 | -9.8% | 77,654 | -12.9% | 0.00% | – |
| Q3 2014 | $796,000 | -57.1% | 89,195 | -62.2% | 0.00% | – |
| Q2 2014 | $1,856,000 | +1.5% | 235,862 | +1.9% | 0.00% | – |
| Q1 2014 | $1,829,000 | +57.3% | 231,352 | +23.9% | 0.00% | – |
| Q4 2013 | $1,163,000 | +280.1% | 186,733 | +115.7% | 0.00% | – |
| Q3 2013 | $306,000 | +646.3% | 86,572 | +308.4% | 0.00% | – |
| Q2 2013 | $41,000 | – | 21,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,918,722 | $6,006,000 | 4.90% |
| Tamarack Advisers, LP | 4,400,000 | $13,882,000 | 2.18% |
| AlphaOne Investment Services, LLC | 580,965 | $1,824,000 | 0.60% |
| CLOUGH CAPITAL PARTNERS L P | 3,061,064 | $9,581,000 | 0.50% |
| Rock Springs Capital Management LP | 1,200,000 | $3,751,000 | 0.24% |
| TURNER INVESTMENTS LLC | 150,000 | $470,000 | 0.16% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 5,397,007 | $16,893,000 | 0.14% |
| SABBY MANAGEMENT, LLC | 484,505 | $1,521,000 | 0.06% |
| PUTNAM INVESTMENTS LLC | 3,673,622 | $11,536,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 28,900 | $90,000 | 0.01% |